The Parexel Podcast | Episode 11: Maintaining Clinical Trial Continuity During COVID-19: The Patient Perspective

Now more than ever it's important to recognize and show our appreciation for clinical trials and the critical role that they play in advancing public health. Since the outbreak of the COVID-19 pandemic we've seen many changes that have been made to clinical trials to maintain continuity. In this podcast, we explore how clinical trials have changed and adapted, and how those changes may impact clinical trials in the future for patients. Ken Getz, professor at Tufts University School of Medicine and the Founder and Chairman of the Center for Information and Study on Clinical Research Participation (CISCRP) moderates this discussion on this most important #ICTD2020 featuring three members of Parexel's Patient Advisory Council along with Parexel’s Chief Medical & Scientific Officer, Dr. Sy Pretorius.

Return to Insights Center

Related Insights

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Article

3 ways to incorporate DE&I in your communications strategy

Sep 29, 2021

Blog

Parexel names first Patient Ambassador

Jun 17, 2022

Blog

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

May 3, 2022

Blog

Patients as Partners 2022: Moving from Insights to Action

May 3, 2022

Blog

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Apr 25, 2022

Podcast

Decentrally Speaking | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities

Mar 22, 2022

Video

Biotech Showcase: Fireside Chat with Jamie Macdonald

Jan 3, 2022

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data

Oct 15, 2021

Whitepaper

Master Protocols from Design to Delivery

Sep 30, 2021

Blog

What COVID Taught Us About Focus, Innovation, and Leadership

Sep 24, 2021